MetaCap

Johnson & Johnson Statistics

NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD

256.48-1.97 (-0.76%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Johnson & Johnson by the numbers

Johnson & Johnson has a market capitalization of $618.09 billion based on 2.41B shares outstanding. Its trailing P/E ratio is 30.0, below the 8-company peer median of 34.2, and its forward P/E is 21.2. The stock trades 3.3% below its 50-day average and 5.7% above its 200-day average.

Average daily trading volume is 7.01M shares, or about $1.80 billion in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

JNJ valuation vs. peer median

JNJ compared with the median of 8 peer companies
MetricJNJPeer medianDifference
Market cap$618.09B$259.13B+139%
P/E (TTM)30.034.2-12%
Forward P/E21.214.9+42%
Dividend yield2.04%2.51%-19%
Avg. volume7.01M7.24M-3%

Peer median across 8 companies: ABBV, MRK, NVS, AZN, LLY, ABT, NVO, PFE.

Valuation

Market cap
$618.09B
Price / sales (latest FY)
6.56

Price and trading

Previous close
258.45
Open
256.22
Day range
251.95 – 257.80
52-week range
184.66 – 281.07
52-week change
+35.21%
Beta
—
Volume
6.05M

Dividends and events

Annual dividend
$5.24
Next earnings date
Oct 13, 2026

Additional statistics

Market Cap
618.09B
Pe
29.96
Forward Pe
21.19
Eps
8.56
Dividend Yield
2.09%
Dividend Rate
5.24
Week52 High
281.07
Week52 Low
184.66
Avg Volume
7.01M
Shares Outstanding
2.41B
Ma50
265.22
Ma200
242.65
Earnings Date
Oct 13, 2026
Pct From52w High
-8.75%
Pct From52w Low
38.89%

Related